𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detection of human tumor-associated antigens by the leukocyte migration in agarose assay

✍ Scribed by A. W. Boddie Jr; Marshall M. Urist; Darwin O. Chee; E. Carmack Holmes; Donald L. Morton


Publisher
John Wiley and Sons
Year
1976
Tongue
French
Weight
555 KB
Volume
18
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Twenty‐three of 36 (64%) lung cancer patients, 19 of 36 (54%) melanoma patients and 18 of 27 (66%) sarcoma patients tested in the leukocyte migration in agarose assay against soluble extracts of histologically similar tumors showed significant inhibition of leukocyte migration. Reactivity to extracts of dissimilar tumors was low. Sera of only 1/13 (7%) lung cancer patients, 2/19 (10%) melanoma patients and 7/21 (33%) sarcoma patients were inhibited by extracts of histologically dissimilar tumors. Only 7–9% of cancer patients reacted to paired extracts of normal tissue from the tumor donors. An average of 13% of sera from normal controls reacted to tumor extracts. Stage of disease and mode of therapy appeared to have little effect on overall reactivity in this assay, although the number of patients within the various categories was small for purposes of statistical analysis. The leukocyte migration in agarose assay shows a sensitivity and specificity to tumor‐associated antigens comparable to that of the older capillary tube method in general use and may facilitate performance of migration inhibition. This assay may not be useful as a prognostic test due to the lack of correlation with stage of disease and treatment modality. However, its high specificity and economical use of tumor antigen suggest applications in tumor antigen purification. The use of soluble tumor antigen preparations may make it possible to purify these antigens further to increase specificity and reactivity.


📜 SIMILAR VOLUMES


Inhibition of leukocyte migration by hum
✍ Anna S. Kadish; Donald M. Marcus; Barry R. Bloom 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 575 KB

## Abstract The existence of CMI to tumor‐associated antigens present in 3 M KCl extracts of breast carcinomas was demonstrated in a group of breast cancer patients by the leukocyte migration inhibition (LMI) assay. When crude KCl extracts were tested, 3 of 5 breast cancer patients gave a positive

Inhibition of human leukocyte migration
✍ A. W. Boddie Jr.; E. Carmack Holmes; Jack A. Roth; Donald L. Morton 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 514 KB

## Abstract The leukocyte migration in agarose assay recently developed by Clausen (Clausen, 1971), was used to test 22 lung cancer patients against soluble extracts of allogeneic lung cancer and allogeneic normal lung. Seventeen were inhibited to a significantly greater degree by at least one tumo

Antigens on melanoma cells detected by l
✍ P. Hersey; M. Honeyman; A. Edwards; E. Adams; W. H. McCarthy 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 795 KB

## Abstract Antibody‐dependent cell‐mediated cytotoxic assays have been used to examine antigens on human melanoma cells obtained either directly from patients or from long‐term melanoma cell lines. A panel of melanoma antisera was selected from human subjects which could be shown not to have signi

Cell-mediated immunity against particula
✍ M. L. Padarathsing; J. H. Dean; J. L. McCoy; D. D. Lewis; J. W. Northing; T. Nat 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

## Abstract Cell‐mediated immunity (CMI), as detected by the agarose microdroplet macrophage migration inhibition (MMI) assay, was investigated using peritoneal exudate cells (PEC) of BALB/c mice and several crude membrane (CM) and solubilized preparations of murine plasmacytomas. The MMI assay was

Detection of tumor-associated antigen in
✍ Elizabeth A. Grimm; Hulbert K. B. Silver; Jack A. Roth; Darwin O. Chee; Rishab K 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 477 KB

## Abstract Spent tissue culture medium (CDM‐S) removed from a single cell line of human malignant melanoma grown in serum‐free CDM, contained tumor‐associated antigenic activity. Antibodies to CDM‐S measured by complement fixation were detected in 44% (31/70) melanoma, 55% (15/27) sarcoma, 63% (24